Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Drugs for Human African Trypanosomiasis: A Twenty First Century Success Story
Emily A. Dickie, Federica Giordani, Matthew K. Gould, et al.
Tropical Medicine and Infectious Disease (2020) Vol. 5, Iss. 1, pp. 29-29
Open Access | Times Cited: 117

Showing 51-75 of 117 citing articles:

G‐Quadruplexes as Key Transcriptional Regulators in Neglected Trypanosomatid Parasites
Ludovica Monti, Marco Di Antonio
ChemBioChem (2023) Vol. 24, Iss. 12
Open Access | Times Cited: 5
Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T. b. brucei hit-compound with improved pharmacokinetic properties
Cyril Fersing, Clotilde Boudot, Romain Paoli-Lombardo, et al.
European Journal of Medicinal Chemistry (2020) Vol. 206, pp. 112668-112668
Open Access | Times Cited: 13
Aminoacyl-tRNA synthetase (AARS) as an attractive drug target in neglected tropical trypanosomatid diseases-Leishmaniasis, Human African Trypanosomiasis and Chagas disease
Vikas Kushwaha, Neena Capalash
Molecular and Biochemical Parasitology (2022) Vol. 251, pp. 111510-111510
Closed Access | Times Cited: 8
Gambiense human African trypanosomiasis: the bumpy road to elimination
Epco Hasker, Andrew Hope, Emmanuel Bottieau
Current Opinion in Infectious Diseases (2022) Vol. 35, Iss. 5, pp. 384-389
Open Access | Times Cited: 8
Neuroimmunology of Common Parasitic Infections in Africa
Richard Idro, Rodney Ogwang, Antonio Barragán, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Semi-Synthetic Analogues of Cryptolepine as a Potential Source of Sustainable Drugs for the Treatment of Malaria, Human African Trypanosomiasis, and Cancer
Yabalu Z. Abacha, Arnold Donkor Forkuo, Stephen Yao Gbedema, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 8
Repurposing of MitoTam: Novel Anti-Cancer Drug Candidate Exhibits Potent Activity against Major Protozoan and Fungal Pathogens
Dominik Arbon, Kateřina Ženíšková, Karolína Šubrtová, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 8
Open Access | Times Cited: 8
Structure‐Activity Relationships, Tolerability and Efficacy of Microtubule‐Active 1,2,4‐Triazolo[1,5‐a]pyrimidines as Potential Candidates to Treat Human African Trypanosomiasis**
Ludovica Monti, Lawrence J. Liu, Carmine Varricchio, et al.
ChemMedChem (2023) Vol. 18, Iss. 20
Open Access | Times Cited: 4
Identification of a small-molecule inhibitor that selectively blocks DNA-binding by Trypanosoma brucei replication protein A1
Aditi Mukherjee, Zakir Hossain, Esteban Erben, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Suramin action in African trypanosomes involves a RuvB-like DNA helicase
Anna Albisetti, Silvan Hälg, Martin Zoltner, et al.
International Journal for Parasitology Drugs and Drug Resistance (2023) Vol. 23, pp. 44-53
Open Access | Times Cited: 4
Cholesterol Efflux Decreases TLR4-Target Gene Expression in Cultured Macrophages Exposed to T. brucei Ghosts
Lawrence P. Fernando, Jing Echesabal-Chen, Murphy Miller, et al.
Microorganisms (2024) Vol. 12, Iss. 8, pp. 1730-1730
Open Access | Times Cited: 1
Single GC base pair recognition by a heterocyclic diamidine: structures, affinities, and dynamics
Edwin N. Ogbonna, J. Ross Terrell, Ananya Paul, et al.
RSC Advances (2024) Vol. 14, Iss. 40, pp. 29675-29682
Open Access | Times Cited: 1
Animal Trypanosomiasis: Challenges and Prospects for New Vaccination Strategies
Samille Henriques Pereira, Felipe Giordano Matos Menezes Alves, Santuza Maria Ribeiro Teixeira
Microorganisms (2024) Vol. 12, Iss. 12, pp. 2575-2575
Open Access | Times Cited: 1
4E Interacting Protein as a Potential Novel Drug Target for Nucleoside Analogues in Trypanosoma brucei
Dorien Mabille, Camila C. Santos, Rik Hendrickx, et al.
Microorganisms (2021) Vol. 9, Iss. 4, pp. 826-826
Open Access | Times Cited: 10
Two-Year Follow-Up of Trypanosoma brucei gambiense Serology after Successful Treatment of Human African Trypanosomiasis: Results of Four Different Sero-Diagnostic Tests
Raquel Inocêncio da Luz, Sara Tablado Alonso, Philippe Büscher, et al.
Diagnostics (2022) Vol. 12, Iss. 2, pp. 246-246
Open Access | Times Cited: 7
Nitroimidazopyrazinones with Oral Activity against Tuberculosis and Chagas Disease in Mouse Models of Infection
Ang Chee Wei, Brendon M. Lee, Colin J. Jackson, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 19, pp. 13125-13142
Open Access | Times Cited: 7
New Pyrano‐4H‐benzo[g]chromene‐5,10‐diones with Antiparasitic and Antioxidant Activities
Ibrahim S. Al Nasr, Jana Jentzsch, Amin Shaikh, et al.
Chemistry & Biodiversity (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 10
Fexinidazole interferes with the growth and structural organization of Trypanosoma cruzi
Aline Araújo Zuma, Wanderley de Souza
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 6
African Trypanosomosis Obliterates DTPa Vaccine-Induced Functional Memory So That Post-Treatment Bordetella pertussis Challenge Fails to Trigger a Protective Recall Response
Magdalena Radwanska, H. Nguyen, Stefan Magez
Vaccines (2021) Vol. 9, Iss. 6, pp. 603-603
Open Access | Times Cited: 8
Modular nanotheranostic agents for protistan parasitic diseases: Magic bullets with tracers
Sutherland K. Maciver, Sumayah Abdelnasir, Ayaz Anwar, et al.
Molecular and Biochemical Parasitology (2023) Vol. 253, pp. 111541-111541
Closed Access | Times Cited: 3
Bis-6-amidino-benzothiazole Derivative that Cures Experimental Stage 1 African Trypanosomiasis with a Single Dose
Livio Racané, Lucija Ptiček, Sanja Koštrun, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 18, pp. 13043-13057
Open Access | Times Cited: 3
Phospholipid Analogues as Chemotherapeutic Agents Against Trypanosomatids
Evanthia Chazapi, George Ε. Magoulas, Kyriakos C. Prousis, et al.
Current Pharmaceutical Design (2020) Vol. 27, Iss. 15, pp. 1790-1806
Closed Access | Times Cited: 6
Toward Chemical Validation of Leishmania infantum Ribose 5-Phosphate Isomerase as a Drug Target
Emily A. Dickie, C. Ronin, Mónica Sá, et al.
Antimicrobial Agents and Chemotherapy (2021) Vol. 65, Iss. 7
Open Access | Times Cited: 6
Role of the inhibitor of serine peptidase 2 (ISP2) of Trypanosoma brucei rhodesiense in parasite virulence and modulation of the inflammatory responses of the host
David Jessula Levy, Amy Goundry, R. Laires, et al.
PLoS neglected tropical diseases (2021) Vol. 15, Iss. 6, pp. e0009526-e0009526
Open Access | Times Cited: 6
Novel Trypanocidal Inhibitors that Block Glycosome Biogenesis by Targeting PEX3–PEX19 Interaction
Mengqiao Li, Stefan Gaussmann, Bettina Tippler, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 6

Scroll to top